SALT AND CRYSTAL FORM OF HETEROCYCLIC DERIVATIVE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF

Title:

SALT AND CRYSTAL FORM OF HETEROCYCLIC DERIVATIVE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF

Document Type and Number:

WIPO Patent Application WO/2024/083204

Kind Code:

A1

Abstract:

The present invention relates to a salt and a crystal form of a heterocyclic derivative inhibitor, and a preparation method therefor and the use thereof. Particularly, the present invention relates to a salt and a crystal form of the compound as represented by general formula (I), a preparation method, a pharmaceutical composition containing a therapeutically effective amount of the salt and/or crystal form, and the use thereof as an inhibitor in the treatment of cancers, wherein the definition of each substituent in general formula (I) is as defined in the description.

More Like This:

WO/2011/064189	NOVEL POLYMORPHIC SHAPES OF METHYL{4,6-DIAMINO-2-[1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDINE-3-YL]PYRIMIDIN-5-YL)CARBAMATE
JP4578773	Delivery of antipsychotics by prescribed inhalation route
JP6193233	Condensed ring heterocyclic compound

Inventors:

ZHAN XIAOLAN (CN)
LI YUANYUAN (CN)
GUO LINSONG (CN)

Application Number:

PCT/CN2023/125513

Publication Date:

April 25, 2024

Filing Date:

October 20, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

SHANGHAI HANSOH BIOMEDICAL CO LTD (CN)
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD (CN)

International Classes:

C07D471/04; A61K31/4353; A61K31/495; A61P35/00; C07D401/14

Domestic Patent References:

WO2021013735A1	2021-01-28
WO2022228387A1	2022-11-03

Foreign References:

CN116143776A	2023-05-23
CN116535401A	2023-08-04

Attorney, Agent or Firm:

GE CHENG & CO., LTD. (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: METHOD, APPARATUS, AND MEDIUM FOR VIDEO PROCESSING

Next Patent: WATER-FREE HUMIDIFICATION MODULE AND AIR CONDITIONER